Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence.

Kampman, K M; Rukstalis, M; Ehrman, R; McGinnis, D E; Gariti, P; Volpicelli, J R; Pettinati, H; O'Brien, C P

Kampman, K M; Rukstalis, M; Ehrman, R; McGinnis, D E; Gariti, P; Volpicelli, J R; Pettinati, H; O'Brien, C P.

Affiliation

Kampman KM; Department of Psychiatry, University of Pennsylvania School of Medicine, USA. kampman@research.trc.upenn.edu

Addict Behav ; 24(2): 287-91, 1999.

Article in En | MEDLINE | ID: mdl-10336110

Subject(s)

Anti-Anxiety Agents/therapeutic use; Cocaine-Related Disorders/drug therapy; Propranolol/therapeutic use; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation/therapeutic use; Controlled Clinical Trials as Topic/methods; Evidence-Based Medicine/methods; Female; Humans; Male; Middle Aged; Patient Compliance; Pilot Projects; Prospective Studies; Research Design; Survival Analysis; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Database: MEDLINE Main subject: Propranolol / Anti-Anxiety Agents / Cocaine-Related Disorders Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Addict Behav Year: 1999 Document type: Article

Search on Google

XML

PubMed Links